JD

Jixin Ding

Principal Scientist at BridgeBio

Jixin (Jason) Ding is a Principal Scientist at BridgeBio, with a professional trajectory that includes a role as a Sr. Scientist at the same company since January 2020. Previously, Jixin served as a Research Scientist at Bristol-Myers Squibb from December 2018 to January 2020, and held a Research Scientist position at Indiana University School of Medicine for a decade, where collaborations focused on cancer drug development and research project design. Earlier experiences include conducting pre-clinical studies targeting PI3K-Akt/Notch and Stat3/Notch pathways at Indiana University, and investigating AKT signaling and its partners in diabetes and cancer during postdoctoral research at Tufts Medical Center and Harvard Medical School. Jixin earned a PhD in Biochemistry and Molecular Biology from Peking University Health Science Center and a Master of Science in Pharmacology from Shandong University.

Links


Org chart

This person is not in the org chart


Teams

This person is not in any teams


  1. This content will be removed shortly.